Results 111 to 120 of about 486,907 (280)
ABSTRACT Companion canines need advances in therapeutic options for solid tumour malignancies. Natural killer (NK) cell infusions offer a promising treatment modality in canines with solid tumours. Autologous natural killer products are limited by dysfunctional immunity and a manufacturing process that delays care whereas allogeneic NK cells offer the ...
Allison M. Weisnicht +11 more
wiley +1 more source
Medical Thoracoscopy in the Management of Malignant Pleural Effusion
Malignant pleural effusion is one of the most common problems that chest physicians face in their everyday practice. The diagnosis of malignant pleural effusion requires either a histological or cytological demonstration of malignant cells in the pleural
YILDIRIM, HÜSEYİN
core +1 more source
ABSTRACT Ménétrier disease (MD) was diagnosed based on hypoalbuminemia and giant gastric folds extending from the body to the fundus in a woman in her 70s. A serum anti‐Helicobacter pylori antibody test and urea breath test yielded negative results.
Takaaki Shamoto +8 more
wiley +1 more source
This review examines the current literature on the application of atomic force microscopy (AFM) to cancer mechanophenotyping, with particular emphasis on cellular Young's modulus and its potential diagnostic significance. A structured electronic search of PubMed, Scopus and Google Scholar was conducted to identify studies published between 1999 and ...
Hermawan Tjoa +4 more
wiley +1 more source
Severe Adverse Reactions Induced by the Chest Injection of Elemene: An Analysis of 7 Cases
Background and objective Malignant pleural effusion (MPE) refers to pleural effusion which arises from primary malignant tumor of pleura or other pleural metastatic tumors.
Fei GAO +4 more
doaj +1 more source
Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study
ABSTRACT Ewing sarcoma, the second most common primary bone cancer in children, requires intensive treatment that may lead to significant long‐term sequelae, particularly in infants. We retrospectively analyzed data from 1621 French patients treated between 1988 and 2015 within the EW88/93/97 or EE99 trials, focusing on 17 infants diagnosed before 24 ...
Elodie Verdier +18 more
wiley +1 more source
Objective: To explore the clinical role of 18 F-FDG PET/CT in distinguishing malignant from benign pleural effusion in pretreatment non-small cell lung cancer (NSCLC) patients.
ZHANG Weishan +4 more
doaj
ABSTRACT Background The International Federation of Gynecology and Obstetrics (FIGO) staging system for advanced ovarian cancer has remained largely static since 2014, with stage IV subdivided into IVA and IVB without further stratification. Emerging evidence suggests substantial prognostic heterogeneity within stage IV, yet large‐scale validation ...
Cheng Fang, Jundong Li, Qiaqia Li
wiley +1 more source
Non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations often exhibit significant tumor reduction following tyrosine kinase inhibitor (TKI) therapy. Residual tumors frequently remain, however, leading to drug resistance and disease progression.
Fedor Moiseenko +31 more
wiley +1 more source
Comparison of measurements in spectral CT between benign and malignant pleural effusion.
Comparison of measurements in spectral CT between benign and malignant pleural effusion.
Yuxin Lei (5088806) +7 more
core +1 more source

